vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and SYNAPTICS Inc (SYNA). Click either name above to swap in a different company.

SYNAPTICS Inc is the larger business by last-quarter revenue ($302.5M vs $268.1M, roughly 1.1× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -4.9%, a 6.2% gap on every dollar of revenue. On growth, SYNAPTICS Inc posted the faster year-over-year revenue change (13.2% vs 9.7%). Over the past eight quarters, SYNAPTICS Inc's revenue compounded faster (12.9% CAGR vs 5.3%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Synaptics, Inc. is an American neural network technologies and computer-to-human interface devices development company based in San Jose, California. It develops touchpads and fingerprint biometrics technology for computer laptops; touch, display driver, and fingerprint biometrics technology for smartphones; and touch, video and far-field voice, low-power AI processors, and wireless technology for smart home devices, wearables, and automobiles. Synaptics sells its products to original equipme...

ACAD vs SYNA — Head-to-Head

Bigger by revenue
SYNA
SYNA
1.1× larger
SYNA
$302.5M
$268.1M
ACAD
Growing faster (revenue YoY)
SYNA
SYNA
+3.5% gap
SYNA
13.2%
9.7%
ACAD
Higher net margin
ACAD
ACAD
6.2% more per $
ACAD
1.4%
-4.9%
SYNA
Faster 2-yr revenue CAGR
SYNA
SYNA
Annualised
SYNA
12.9%
5.3%
ACAD

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ACAD
ACAD
SYNA
SYNA
Revenue
$268.1M
$302.5M
Net Profit
$3.6M
$-14.8M
Gross Margin
43.5%
Operating Margin
-1.7%
-5.0%
Net Margin
1.4%
-4.9%
Revenue YoY
9.7%
13.2%
Net Profit YoY
-922.2%
EPS (diluted)
$0.02
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
SYNA
SYNA
Q1 26
$268.1M
Q4 25
$284.0M
$302.5M
Q3 25
$278.6M
$292.5M
Q2 25
$264.6M
$282.8M
Q1 25
$244.3M
$266.6M
Q4 24
$259.6M
$267.2M
Q3 24
$250.4M
$257.7M
Q2 24
$242.0M
$247.4M
Net Profit
ACAD
ACAD
SYNA
SYNA
Q1 26
$3.6M
Q4 25
$273.6M
$-14.8M
Q3 25
$71.8M
$-20.6M
Q2 25
$26.7M
$-4.7M
Q1 25
$19.0M
$-21.8M
Q4 24
$143.7M
$1.8M
Q3 24
$32.8M
$-23.1M
Q2 24
$33.4M
$208.3M
Gross Margin
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
90.8%
43.5%
Q3 25
92.2%
42.6%
Q2 25
92.2%
43.0%
Q1 25
91.7%
43.4%
Q4 24
91.6%
45.7%
Q3 24
92.5%
46.9%
Q2 24
92.5%
45.8%
Operating Margin
ACAD
ACAD
SYNA
SYNA
Q1 26
-1.7%
Q4 25
6.1%
-5.0%
Q3 25
12.8%
-7.9%
Q2 25
12.2%
-8.6%
Q1 25
7.9%
-9.9%
Q4 24
59.1%
-5.7%
Q3 24
12.6%
-11.0%
Q2 24
12.6%
-12.6%
Net Margin
ACAD
ACAD
SYNA
SYNA
Q1 26
1.4%
Q4 25
96.3%
-4.9%
Q3 25
25.8%
-7.0%
Q2 25
10.1%
-1.7%
Q1 25
7.8%
-8.2%
Q4 24
55.4%
0.7%
Q3 24
13.1%
-9.0%
Q2 24
13.8%
84.2%
EPS (diluted)
ACAD
ACAD
SYNA
SYNA
Q1 26
$0.02
Q4 25
$1.61
$-0.38
Q3 25
$0.42
$-0.53
Q2 25
$0.16
$-0.13
Q1 25
$0.11
$-0.56
Q4 24
$0.86
$0.05
Q3 24
$0.20
$-0.58
Q2 24
$0.20
$5.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
SYNA
SYNA
Cash + ST InvestmentsLiquidity on hand
$437.4M
Total DebtLower is stronger
$836.0M
Stockholders' EquityBook value
$1.4B
Total Assets
$1.6B
$2.6B
Debt / EquityLower = less leverage
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
$177.7M
$437.4M
Q3 25
$258.0M
$459.9M
Q2 25
$253.6M
$452.5M
Q1 25
$217.7M
$421.4M
Q4 24
$319.6M
$596.1M
Q3 24
$155.1M
$853.6M
Q2 24
$177.1M
$876.9M
Total Debt
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
$836.0M
Q3 25
$835.4M
Q2 25
$834.8M
Q1 25
$834.2M
Q4 24
$832.5M
Q3 24
Q2 24
$983.5M
Stockholders' Equity
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
$1.2B
$1.4B
Q3 25
$917.3M
$1.4B
Q2 25
$822.4M
$1.4B
Q1 25
$765.2M
$1.4B
Q4 24
$732.8M
$1.4B
Q3 24
$577.2M
$1.5B
Q2 24
$516.7M
$1.5B
Total Assets
ACAD
ACAD
SYNA
SYNA
Q1 26
$1.6B
Q4 25
$1.6B
$2.6B
Q3 25
$1.3B
$2.6B
Q2 25
$1.2B
$2.6B
Q1 25
$1.1B
$2.6B
Q4 24
$1.2B
$2.5B
Q3 24
$976.9M
$2.8B
Q2 24
$914.1M
$2.8B
Debt / Equity
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
0.60×
Q3 25
0.60×
Q2 25
0.60×
Q1 25
0.60×
Q4 24
0.60×
Q3 24
Q2 24
0.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
SYNA
SYNA
Operating Cash FlowLast quarter
$29.8M
Free Cash FlowOCF − Capex
$18.2M
FCF MarginFCF / Revenue
6.0%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$154.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
$-48.7M
$29.8M
Q3 25
$74.3M
$30.2M
Q2 25
$64.0M
$57.2M
Q1 25
$20.3M
$73.4M
Q4 24
$40.4M
$22.8M
Q3 24
$63.2M
$-11.4M
Q2 24
$25.0M
$65.0M
Free Cash Flow
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
$18.2M
Q3 25
$73.9M
$18.0M
Q2 25
$50.6M
Q1 25
$68.0M
Q4 24
$18.1M
Q3 24
$63.2M
$-20.5M
Q2 24
$57.3M
FCF Margin
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
6.0%
Q3 25
26.5%
6.2%
Q2 25
17.9%
Q1 25
25.5%
Q4 24
6.8%
Q3 24
25.2%
-8.0%
Q2 24
23.2%
Capex Intensity
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
3.8%
Q3 25
0.1%
4.2%
Q2 25
2.3%
Q1 25
2.0%
Q4 24
1.8%
Q3 24
0.0%
3.5%
Q2 24
3.1%
Cash Conversion
ACAD
ACAD
SYNA
SYNA
Q1 26
Q4 25
-0.18×
Q3 25
1.03×
Q2 25
2.40×
Q1 25
1.07×
Q4 24
0.28×
12.67×
Q3 24
1.93×
Q2 24
0.75×
0.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Segment breakdown not available.

SYNA
SYNA

Enterprise And Automotive Product Applications$161.1M53%
Internet Of Things Product Applications$93.2M31%
Mobile Product Applications$48.2M16%

Related Comparisons